Key result
Von Willebrand disease was associated with a decreased likelihood of ischemic heart disease compared to patients without the disease.
Why the study?
Elevated vWF levels are associated with increased IHD risk, but whether vWF deficiency in patients with vWD protects against IHD remains unclear.
Does von Willebrand disease reduce the prevalence of ischemic heart disease in hospitalized adults aged 18-75?
Cross-Sectional (n=224,475,443)
Yes
Does von Willebrand disease reduce the prevalence of ischemic heart disease in hospitalized adults aged 18-75?
von Willebrand disease is associated with a significantly decreased prevalence of ischemic heart disease, suggesting a cardioprotective effect of vWF deficiency.
Answers are grounded in this paper and cite their sources.
Should not change IHD risk assessment or vWD management; leaves open whether vWF deficiency is cardioprotective.
von Willebrand factor (vWF) aids coagulation at sites of vessel injury. Elevated vWF levels have been associated with an increased risk of ischemic heart disease (IHD); however, it is unclear whether vWF deficiency, seen in patients with von Willebrand disease (vWD), protects people against IHD. We determined and compared the prevalence and risk of IHD in patients with versus without vWD by using data from the National Inpatient Sample (2009-2014), excluding patients younger than 18 and older than 75 years. The primary outcome was the odds ratio (OR) of IHD in patients with versus without vWD. Secondary outcomes were major medical comorbidities and demographic characteristics in patients with vWD. Of 224,475,443 weighted hospital-discharge samples, we identified 82,809 patients with a vWD diagnosis. The odds of IHD were lower in patients with vWD than in those without (OR=0.54; 95% CI, 0.52-0.56). After multivariable logistic regression analysis and adjustment for age, sex, and typical IHD risk factors (hypertension, smoking, diabetes, hyperlipidemia, chronic kidney disease, obesity, and family history of IHD), the likelihood of IHD remained lower in patients with vWD than in patients without (OR=0.65; 95% CI, 0.63-0.67). Our study shows that vWF deficiency, as seen in patients with vWD, is associated with a decreased prevalence of IHD. Further investigation may confirm these findings.
No takes yet. Share an insight, caveat, or question.
Mihyawi et al. (2022) conducted a cross-sectional in Ischemic heart disease (n=224,475,443). von Willebrand disease vs. Patients without von Willebrand disease was evaluated on Ischemic heart disease (OR 0.65, 95% CI 0.63-0.67). Von Willebrand disease was associated with a decreased likelihood of ischemic heart disease compared to patients without the disease.
Synapse has enriched 10 related papers. Consider them for comparative context: